IXICO on Huntington's disease treatments: A turning point for Neuroscience

By Proactive Investors / November 04, 2026 / www.youtube.com / Article Link

IXICO CEO Bram Goorden discusses the company's latest ?2.7 million Phase 3 Huntington's disease clinical trial contract its ...

Recent News

Big Gold Q3/26 strong results continue

November 02, 2026 / www.canadianminingreport.com

Gold stocks decline as major sector rotation continues

November 02, 2026 / www.canadianminingreport.com

Gold stocks slump in global sector rotation

October 26, 2026 / www.canadianminingreport.com

Newmont starts Q3/26 Big Gold results with another strong quarter

October 26, 2026 / www.canadianminingreport.com

Gold stocks down on metal dip and equities drop

October 19, 2026 / www.canadianminingreport.com

See all >